As Life Sciences companies comes to rely increasingly on digital capabilities and good data for efficiency and competitive advantage, it’s critical that they harness system…
Adverse event (AE) case intake in Life Sciences is crying out for disruption by AI. And now, at last, Generative AI and Large Language Models…
Medical writing in pharma is ripe for disruption, across use cases linked to regulatory documentation and safety report summaries, and Generative AI (GenAI) promises exactly…
Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines and treatment faster. Rare diseases are no longer rare. Every year,…
Pharmacy First could pave the way for pharmacy to become the backbone of primary care in England – but pharmacists will need investment and support…
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Here, Alpharmaxim’s William Hind…
Effective vendor selection and contracting is critical to support regulatory information management capabilities that increasingly lie at the heart of quality and clinical processes. Romuald…
As trials become increasingly complex, companies share how leaving behind legacy EDC systems can save thousands of hours during study build and testing. In today’s…
The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD and this number is…
